Predictors and Prognostic Value of Myocardial Injury During Transcatheter Aortic Valve Implantation
暂无分享,去创建一个
B. Bouma | K. Koch | J. Piek | B. D. de Mol | J. Henriques | J. Baan | E. Wiegerinck | Z. Yong | M. Vis | Riccardo Cocchieri | K. Boerlage-van Dijk
[1] S. Windecker,et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, The Journal of thoracic and cardiovascular surgery.
[2] Stuart J Pocock,et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.
[3] P. Jüni,et al. Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes. , 2011, American heart journal.
[4] P. Pibarot,et al. Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation. , 2011, Journal of the American College of Cardiology.
[5] B. Carabello. Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery , 2011, Current cardiology reports.
[6] Pascal Vranckx,et al. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. , 2011, Journal of the American College of Cardiology.
[7] P. Serruys,et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium , 2010, European heart journal.
[8] P. Wenaweser,et al. Transcatheter aortic valve implantation: predictors of procedural success--the Siegburg-Bern experience. , 2010, European heart journal.
[9] T. Tønnessen,et al. Cold blood cardioplegia reduces the increase in cardiac enzyme levels compared with cold crystalloid cardioplegia in patients undergoing aortic valve replacement for isolated aortic stenosis. , 2010, The Journal of thoracic and cardiovascular surgery.
[10] Z. Yong. Clinical and hemodynamic effects of transcatheter aortic valve implantation , 2012 .
[11] I. Porto,et al. Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition. , 2009, QJM : monthly journal of the Association of Physicians.
[12] R. Gupta,et al. Distal myocardial protection with intracoronary beta blocker when added to a Gp IIb/IIIa platelet receptor blocker during percutaneous coronary intervention improves clinical outcome , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[13] Raimund Erbel,et al. Impact of atherosclerotic plaque composition on coronary microembolization during percutaneous coronary interventions , 2008, Basic Research in Cardiology.
[14] A. Alghamdi,et al. Troponin after cardiac surgery: a predictor or a phenomenon? , 2008, The Annals of thoracic surgery.
[15] W. Luo,et al. Effect of ischemic postconditioning in adult valve replacement. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[16] A. Ducharme,et al. Surgical aspects of endovascular retrograde implantation of the aortic CoreValve bioprosthesis in high-risk older patients with severe symptomatic aortic stenosis. , 2007, The Journal of thoracic and cardiovascular surgery.
[17] Colin Berry,et al. Novel therapeutic aspects of percutaneous aortic valve replacement with the 21F CoreValve Revalving™ System , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[18] S. Di Stefano,et al. Plasma troponins as markers of myocardial damage during cardiac surgery with extracorporeal circulation. , 2007, The Tohoku journal of experimental medicine.
[19] Lukas Altwegg,et al. Percutaneous Transarterial Aortic Valve Replacement in Selected High-Risk Patients With Aortic Stenosis , 2007, Circulation.
[20] Thomas Walther,et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. , 2007, Journal of the American College of Cardiology.
[21] A. Kalangos,et al. Cardioprotective effects of acute normovolemic hemodilution in patients with severe aortic stenosis undergoing valve replacement , 2007, Transfusion.
[22] Thomas Felderhoff,et al. Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease: The Siegburg First-in-Man Study , 2006, Circulation.
[23] G. Baron,et al. Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: Association with postoperative cardiac dysfunction and 1-year mortality* , 2006, Critical care medicine.
[24] A. Cribier,et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. , 2006, Journal of the American College of Cardiology.
[25] J. Herrmann. Peri-procedural myocardial injury: 2005 update. , 2005, European heart journal.
[26] G. Grunwald,et al. Comparison of short-term mortality risk factors for valve replacement versus coronary artery bypass graft surgery. , 2004, The Annals of thoracic surgery.
[27] J. Ioannidis,et al. Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention. , 2003, Journal of the American College of Cardiology.
[28] B. Uretsky,et al. Distal Myocardial Protection During Percutaneous Coronary Intervention With an Intracoronary &bgr;‐Blocker , 2003, Circulation.
[29] Fernando Hornero Sos,et al. Left ventricular mass index in aortic valve surgery: a new index for early valve replacement? , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[30] A. Varga,et al. How Can Coronary Flow Reserve Be Altered by Severe Aortic Stenosis? , 2002, Echocardiography.
[31] E. Vicaut,et al. Cardiac Troponin I Is an Independent Predictor of In-hospital Death after Adult Cardiac Surgery , 2002, Anesthesiology.
[32] M. Simoons,et al. Minor Myocardial Damage and Prognosis: Are Spontaneous and Percutaneous Coronary Intervention–Related Events Different? , 2002, Circulation.
[33] K. Eagle,et al. Implications of increased left ventricular mass index on in-hospital outcomes in patients undergoing aortic valve surgery. , 2001, The Journal of thoracic and cardiovascular surgery.
[34] S. Lasocki,et al. Utility of cardiac troponin measurement after cardiac surgery. , 2001, Clinica chimica acta; international journal of clinical chemistry.
[35] R. Fitzgerald,et al. Usefulness of cardiac troponin I in patients undergoing open heart surgery. , 2001, American heart journal.
[36] M. Volmer,et al. Creatine kinase MB, troponin I, and troponin T release patterns after coronary artery bypass grafting with or without cardiopulmonary bypass and after aortic and mitral valve surgery. , 2001, Clinical chemistry.
[37] A. Penttilä,et al. Reperfusion injury associated with one-fourth of deaths after coronary artery bypass grafting. , 2000, The Annals of thoracic surgery.
[38] R. Califf,et al. Minimal myocardial damage during coronary intervention is associated with impaired outcome. , 1999, European heart journal.
[39] T. Kawamoto,et al. Restricted coronary flow reserve in patients with mitral regurgitation improves after mitral reconstructive surgery. , 1998, Journal of the American College of Cardiology.
[40] J. Viel,et al. Crystalloid versus cold blood cardioplegia and cardiac troponin I release. , 1997, Circulation.
[41] G. Toubin,et al. Use of cardiac troponin I as a marker of perioperative myocardial ischemia. , 1995, The Annals of thoracic surgery.
[42] M. Cheitlin,et al. Coronary blood flow reserve in acute aortic regurgitation. , 1995, Journal of the American College of Cardiology.
[43] G. Aurigemma,et al. Left ventricular hypertrophy and mortality after aortic valve replacement for aortic stenosis. A high risk subgroup identified by preoperative relative wall thickness. , 1993, Journal of the American College of Cardiology.
[44] S. Hagl,et al. Non-invasive assessment of perioperative myocardial cell damage by circulating cardiac troponin T. , 1991, British heart journal.
[45] N. Reichek,et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.
[46] C. Olin,et al. Myocardial injury and ck‐mb release during aortic valve surgery with selective coronary perfusion , 1981, Clinical cardiology.
[47] B. Bouma,et al. Percutaneous implantation of the CoreValve aortic valve prosthesis in patients at high risk or rejected for surgical valve replacement: Clinical evaluation and feasibility of the procedure in the first 30 patients in the AMC-UvA. , 2010, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.
[48] M. Nienhuis,et al. Prognostic implications of myocardial injury around percutaneous coronary interventions , 2008 .